Papers - Tasaka Sadatomo
-
急性呼吸促迫症候群
田坂 定智
呼吸器症候群（第3版）Ⅱ 197 - 201 2021
-
Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020-2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society.
Kamata H, Takamatsu K, Fukunaga K, Chubachi S, Nakagawara K, Namkoong H, Terai H, Tanaka K, Sato S, Hagiwara E, Takei R, Kondoh Y, Takazono T, Hashimoto M, Tasaka S, Ohrui T, Tanino Y, Mineshita M, Komase Y, Miyazaki K, Nishikawa M, Ando A, Kita H, Ichihara E, Ohshimo S, Murata Y, Ishida M, Kobayashi S, Uchida T, Tateno H, Ikari J, Terashima T, Kozu Y, Tateishi T, Shinkai M, Sagara H, To Y, Ito Y, Yamamoto M, Yamamoto Y, Kita T, Ito Y, Tomii K, Fujita Y, Funaki Y, Yatera K, Yamasue M, Komiya K, Kozawa S, Manabe H, Hozumi H, Horiguchi T, Kitajima T, Nakano Y, Nagaoka T, Hojo M, Ebihara A, Kobayashi M, Takayama K, Jinta T, Sawai T, Fukuda Y, Kaneko T, Chin K, Ogura T, Mukae H, Ishii M, Yokoyama A
Respiratory investigation 62 ( 4 ) 572 - 579 2024.7
-
Endocrine immune-related adverse event is a prognostic biomarker independent of lead-time bias.
Ishidoya M, Makiguchi T, Tanaka H, Miura T, Nunomura Y, Miura D, Morimoto T, Hasegawa Y, Taima K, Tasaka S
Lung cancer (Amsterdam, Netherlands) 192 107790 2024.6
-
Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a post-marketing surveillance study.
Kameda H, Tasaka S, Takahashi T, Suzuki K, Soeda N, van Hoogstraten H, Diab R, Tanaka Y
Modern rheumatology 2024.5
-
Real-time MBDi-RPA using methyl-CpG binding protein 2: A real-time detection method for simple and rapid estimation of CpG methylation status.
Ishidoya M, Fujita T, Tasaka S, Fujii H
Analytica chimica acta 1302 342486 2024.5
-
TMEM2 suppresses TLR3-mediated IFN-β/ISG56/CXCL10 expression in BEAS-2B bronchial epithelial cells.
Kobori Y, Tachizaki M, Imaizumi T, Tanaka Y, Seya K, Miki Y, Kawaguchi S, Matsumiya T, Tobisawa Y, Ohyama C, Tasaka S
Molecular biology reports 51 ( 1 ) 417 2024.3
-
TMEM2 suppresses TLR3-mediated IFN-β/ISG56/CXCL10 expression in BEAS-2B bronchial epithelial cells.
Kobori Y, Tachizaki M, Imaizumi T, Tanaka T, Seya K, Miki Y, Kawaguchi S, Matsumiya T, Tobisawa Y, Ohyama C, Tasaka S.
Mol Biol Rep. 2024.3
-
Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.
Akita T, Ariyasu R, Kakuto S, Miyadera K, Kiritani A, Tsugitomi R, Amino Y, Uchibori K, Kitazono S, Yanagitani N, Tasaka S, Nishio M.
Thorac Cancer 2024.2
-
Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.
Akita T, Ariyasu R, Kakuto S, Miyadera K, Kiritani A, Tsugitomi R, Amino Y, Uchibori K, Kitazono S, Yanagitani N, Tasaka S, Nishio M
Thoracic cancer 15 ( 10 ) 788 - 796 2024.2
-
Role of G-protein-coupled estrogen receptor in the pathogenesis of chronic asthma.
Itoga M, Ishioka Y, Makiguchi T, Tanaka H, Taima K, Saito N, Tomita H, Tasaka S.
Immunol Lett 2024.2
-
Role of G-protein-coupled estrogen receptor in the pathogenesis of chronic asthma.
Itoga M, Ishioka Y, Makiguchi T, Tanaka H, Taima K, Saito N, Tomita H, Tasaka S
Immunology letters 265 16 - 22 2024.2
-
Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study.
Ishioka Y, Tanaka H, Makiguchi T, Fujishima S, Nunomura Y, Sakamoto H, Shiratori T, Taima K, Tasaka S
Oncology letters 27 ( 1 ) 22 2024.1
-
急性呼吸窮迫症候群（ARDS）．
田坂定智
門脇 孝，小室一成，宮地良樹 監修．日常診療に活かす診療ガイドラインUP-TO-DATE 2024-2025 2024
-
A Case of Disseminated Non-tuberculous Mycobacteriosis with a Skull Lesion Controlled by Resection after Exacerbation during Antimicrobial Chemotherapy in a Patient Positive for Anti-IFN-γ-neutralizing Autoantibodies
Chubachi Kei, Taima Kageaki, ishidoya Mina, Tanaka Yusuke, Kurose Akira, Tasaka Sadatomo
Internal Medicine advpub ( 0 ) 2024
-
Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy-controlled, phase 2 multicenter study (ONE-BRIDGE).
Ichikado K, Kotani T, Kondoh Y, Imanaka H, Johkoh T, Fujimoto K, Nunomiya S, Kawayama T, Sawada M, Jenkins E, Tasaka S, Hashimoto S.
Stem Cell Res Ther. 2023.8
-
Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy-controlled, phase 2 multicenter study (ONE-BRIDGE).
Ichikado K, Kotani T, Kondoh Y, Imanaka H, Johkoh T, Fujimoto K, Nunomiya S, Kawayama T, Sawada M, Jenkins E, Tasaka S, Hashimoto S
Stem cell research & therapy 14 ( 1 ) 217 2023.8
-
第1土曜特集 ARDSの治療戦略--個別化診療への道筋 その他の治療 ARDSに対する間葉系幹細胞治療
田坂 定智
医学のあゆみ 286 ( 1 ) 98 - 102 2023.7
-
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance.
Kameda H, Tasaka S, Takahashi T, Suzuki K, Soeda N, Tanaka Y.
Modern Rheumatol 2023.6
-
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance.
Kameda H, Tasaka S, Takahashi T, Suzuki K, Soeda N, Tanaka Y
Modern rheumatology 34 ( 3 ) 444 - 452 2023.6
-
Differential proteomic analysis and pathogenic effects of outer membrane vesicles derived from Acinetobacter baumannii under normoxia and hypoxia.
Suzuki S, Subsomwong P, Narita K, Kawai N, Ishiai T, Teng W, Sukchawalit R, Nakane A, Tasaka S, Asano K.
PLoS One 2023.5